Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Cell Communication and Signaling : CCS
|
April 22, 2021
Protein phosphatases in TLR signaling
Clovis H T Seumen, Tanja M Grimm, Christof R Hauck
The Journal of Cell Biology
|
October 29, 2020
PPM1F controls integrin activity via a conserved phospho-switch
Tanja M Grimm, Nina I Dierdorf, Karin Betz, et al.
Cell Chemical Biology
|
April 20, 2022
Lockdown, a selective small-molecule inhibitor of the integrin phosphatase PPM1F, blocks cancer cell invasion
Tanja M Grimm, Marleen Herbinger, Lena Krüger, et al.
BMC Biology
|
June 19, 2025
The phosphatase PPM1F, a negative regulator of integrin activity, is essential for embryonic development and controls tumor cell invasion
Tanja M Grimm, Nina I Dierdorf, Marleen Herbinger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 19, 2022
Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants
Daniel Junker, Matthias Becker, Teresa R Wagner, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Cell Communication and Signaling : CCS
|
April 22, 2021
Protein phosphatases in TLR signaling
Clovis H T Seumen, Tanja M Grimm, Christof R Hauck
The Journal of Cell Biology
|
October 29, 2020
PPM1F controls integrin activity via a conserved phospho-switch
Tanja M Grimm, Nina I Dierdorf, Karin Betz, et al.
Cell Chemical Biology
|
April 20, 2022
Lockdown, a selective small-molecule inhibitor of the integrin phosphatase PPM1F, blocks cancer cell invasion
Tanja M Grimm, Marleen Herbinger, Lena Krüger, et al.
BMC Biology
|
June 19, 2025
The phosphatase PPM1F, a negative regulator of integrin activity, is essential for embryonic development and controls tumor cell invasion
Tanja M Grimm, Nina I Dierdorf, Marleen Herbinger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 19, 2022
Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants
Daniel Junker, Matthias Becker, Teresa R Wagner, et al.
Page
of 1